Tandem Diabetes Care (TNDM) Non-Current Assets (2013 - 2026)

Tandem Diabetes Care (TNDM) has reported Non-Current Assets for 14 consecutive years, with $349.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-Current Assets rose 33.97% year-over-year to $349.6 million; the trailing twelve-month figure through Jun 2026 stood at $1.1 billion (up 17.45% YoY), and the FY2025 full-year result was $263.0 million, up 8.14% from the prior year.
• Non-Current Assets rose to $349.6 million in Q2 2026 per TNDM's latest filing, from $266.3 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $349.6 million in Q2 2026 and bottomed at $181.8 million in Q3 2023.
• Historically, Non-Current Assets has averaged $227.4 million across 5 years, with a median of $205.4 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Non-Current Assets surged 123.66% in 2022, then retreated 14.75% in 2023.
• Over 5 years, Non-Current Assets stood at $202.8 million in 2022, then rose by 0.92% to $204.7 million in 2023, then gained by 18.81% to $243.2 million in 2024, then increased by 8.14% to $263.0 million in 2025, then jumped by 32.93% to $349.6 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $349.6 million, $266.3 million, and $263.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.